About this trial
Spinal cord injury patients often present with musculoskeletal comorbidities, including osteoarthritis. Early detection of cartilage damage is important for preventing osteoarthritis progression. This study aims to compare the talar cartilage thicknesses of spinal cord injury patients with healthy subjects. The secondary aim is to investigate a correlation between the talar cartilage thickness and disease-related parameters. The patient group is to be assessed for talar cartilage thickness (via ultrasound), functional status, spasticity, and ambulation levels.
Eligibility criteria
Qualifiers
Aged between 18 to 60 years,
Cervical, thoracal or lumber level of spinal cord injury
AIS (American Spinal Injury Association Impairment Scale) Level A, B, C, or D
Assisted ambulation of any kind
Disqualifiers
Patients with sacral level injury
AIS E
MAS 4 level of spasticity
History of any lower extremity operation
Trial design
Treatments tested in this trial
- Not listed